Albemarle revenue and financials
$104.59Change from previous close: −0.42%Absolute change: −$0.44
In the fiscal year ended December 2025, Albemarle reported revenue of $5.14B (−4.37% year over year). The net loss was $510.63M.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −4.37%
- 2025 vs 2024
- Net margin
- -9.9%
- 2024: -21.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 1,743 | 1,429 | 1,428 | 1,308 | 1,330 | — |
| Cost of revenue | 1,153 | 928 | 1,230 | 1,190 | 1,133 | — |
| Gross profit | 590 | 501 | 198 | 118 | 197 | — |
| Selling, general and administrative | 126 | 137 | 156 | 139 | 132 | — |
| Research and development | 3.7 | 9.2 | 12.2 | 12.7 | 12.4 | — |
| Operating income | 460 | 354 | 30.3 | -33.6 | 52.0 | — |
| EBIT | 473 | 287 | -227 | -188 | 41.0 | — |
| EBITDA | 628 | 445 | -63.5 | -23.7 | 210 | — |
| Interest expense | 30.9 | 33.1 | 57.8 | 51.0 | 49.9 | — |
| Pre-tax income | 442 | 254 | -285 | -239 | -9.0 | — |
| Income tax | 94.0 | 21.5 | 157 | -30.6 | 34.1 | — |
| Net income | 480 | 319 | -414 | -161 | 22.9 | — |
| Net income to common shareholders | 438 | 277 | -456 | -202 | -18.8 | — |
| Basic EPS | 3.72 | 2.35 | -3.87 | -1.72 | -0.16 | — |
| Diluted EPS | 3.52 | 2.34 | -3.87 | -1.72 | -0.16 | — |
| Average shares (basic) | 118 | 118 | 118 | 118 | 118 | — |
| Average shares (diluted) | 136 | 119 | 118 | 118 | 118 | — |